Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARW.L Share News (ARW)

  • There is currently no data for ARW

Friday broker round-up UPDATE

Fri, 09th May 2014 08:44
Advanced Medical Solutions: Numis ups target price from 105p to 121p and retains its hold recommendation.Arrow Global: Numis upgrades from add to buy with a target price of 285p.Bank of Georgia: Numis downgrades from buy to hold with a target price of 2708p.Barclays: Citi lowers target price from 315p to 305p and maintains a buy recommendation. Numis upgrades from hold to add with a target price of 280p.Britvic: Investec increases target price from 672p to 716p retaining its hold recommendation.Centrica: Deutsche Bank cuts target price from 300p to 290p maintaining its hold recommendation.Gemfields: Investec shifts target price from 40p to 42.5p retaining its buy recommendation.Grafton Group: Investec ups target price from 690p to 710p upgrading from add to buy.Greencore: Investec cuts target price from 285p to 273p downgrading from buy to add.IMI: Jefferies lowers target price from 1750p to 1740p keeping a buy recommendation.Intertek Group: Credit Suisse increases target price from 3200p to 3500p upgrading to outperform.Johnston Press: Numis places its target price and its sell recommendation under review.Keywords Studios: Numis raises target price from 180p to 205p and reiterates a buy recommendation.Morgan Advanced Materials: Investec cuts target price from 415p to 395p, while leaving its buy recommendation unchanged.Randgold Resources: Deutsche Bank ups target price from 4990p to 5000p and reiterates a buy recommendation. Numis reduces target price from 6200p to 5900p, while staying with its buy recommendation.RPS Group: Panmure Gordon increases target price from 315p to 350p upgrading from hold to buy.Sage Group: Credit Suisse moves target price from 347p to 360p maintaining an underperform rating.Serco Group: UBS reduces target price from 400p to 300p and downgrades from neutral to sell.Shire Pharmaceuticals: Citi raises target price from 4000p to 4100p and retains its buy recommendation.SSE: Deutsche Bank cuts target price from 1360p to 1340p and keeps a hold recommendation.

Related News

Gemfields shares tumble as CEO Sean Gilbertson exits amid challenges
14 hours ago

Gemfields shares tumble as CEO Sean Gilbertson exits amid challenges

(Alliance News) - Gemfields Group Ltd said on Tuesday Chief Executive Officer Sean Gilbertson will step down, with effect from July 15.

Gemfields generates $23.1m in auction, warns of Montepuez issues
16 hours ago

Gemfields generates $23.1m in auction, warns of Montepuez issues

(Sharecast News) - Gemfields said on Tuesday that its first Trade Select ruby auction generated $23.1m, although it warned that lower grades, plant co...

SSE welcomes 'Beyond 2030' plan for UK electricity network upgrades
17 hours ago

SSE welcomes 'Beyond 2030' plan for UK electricity network upgrades

(Alliance News) - SSE PLC on Tuesday said it welcomes the National Energy System Operator's 'Beyond 2030 Update', anticipating further investment for ...

ARW.L News

IN BRIEF: Sherwood Acquisitions completes Arrow Global takeover
12 Oct 2021

IN BRIEF: Sherwood Acquisitions completes Arrow Global takeover

IN BRIEF: Sherwood Acquisitions completes Arrow Global takeover

EARNINGS UPDATES: Colefax profit surges; MJ Hudson plans maiden payout
12 Aug 2021

EARNINGS UPDATES: Colefax profit surges; MJ Hudson plans maiden payout

EARNINGS UPDATES: Colefax profit surges; MJ Hudson plans maiden payout

UK earnings, trading statements calendar - next 7 days
5 Aug 2021

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs
30 Jul 2021

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs

EXECUTIVE CHANGES: All change for ImmuPharma board as CEO departs

UK shareholder meetings calendar - next 7 days
26 May 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy
21 May 2021

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

TRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy

DIRECTOR DEALINGS: New Homeserve chair invests almost GBP500,000
19 May 2021

DIRECTOR DEALINGS: New Homeserve chair invests almost GBP500,000

DIRECTOR DEALINGS: New Homeserve chair invests almost GBP500,000

UK shareholder meetings calendar - next 7 days
14 May 2021

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days